Recombinant FVIIa for intractable hemorrhage: more questions than answers

被引：19

作者：

Key, NS ^{[1
]}

机构：

[1] Univ Minnesota, Sch Med, Div Hematol Oncol & Transplantat, Dept Med, Minneapolis, MN 55455 USA

来源：

TRANSFUSION | 2003年 / 43卷 / 12期

关键词：

D O I：

10.1111/j.0041-1132.2003.00633.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1649 / 1651

页数：3

共 18 条

[1] Activation of coagulation by administration of recombinant factor VIIa elicits interleukin 6 (IL-6) and IL-8 release in healthy human subjects [J].

de Jonge, E ;

Friederich, PW ;

Vlasuk, GP ;

Rote, WE ;

Vroom, MB ;

Levi, M ;

Van der Poll, T .

CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 2003, 10 (03) :495-497

[2] Ongoing NovoSeven® trials [J].

Erhardtsen, E .

INTENSIVE CARE MEDICINE, 2002, 28 (Suppl 2) :S248-S255

[3] Effect of recombinant activated factor VII on perioperative blood loss in patients undergoing retropubic prostatectomy:: a double-blind placebo-controlled andomised trial [J].

Friederich, PW ;

Herny, CP ;

Messelink, EJ ;

Geerdink, MG ;

Keller, T ;

Kurth, KH ;

Büller, HR ;

Levi, M .

LANCET, 2003, 361 (9353) :201-205

[4] The role of recombinant factor VIIa(FVIIa) in fibrin structure in the absence of FVIII/FIX [J].

He, S ;

Blombäck, M ;

Ekman, GJ ;

Hedner, U .

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2003, 1 (06) :1215-1219

[5] Potential role for rFVIIa in transfusion medicine [J].

Hedner, U ;

Erhardtsen, E .

TRANSFUSION, 2002, 42 (01) :114-124

[6] NovoSeven® as a universal haemostatic agent [J].

Hedner, U .

BLOOD COAGULATION & FIBRINOLYSIS, 2000, 11 :S107-S111

[7] Reduced transfusion requirements by recombinant factor VIIa in orthotopic liver transplantation - A pilot study [J].

Hendriks, HGD ;

Meijer, K ;

de Wolf, JTM ;

Klompmaker, IJ ;

Porte, RJ ;

de Kam, PJ ;

Hagenaars, AJM ;

Melsen, T ;

Slooff, MJH ;

van der Meer, J .

TRANSPLANTATION, 2001, 71 (03) :402-405

[8] The action of high-dose factor VIIa (FVIIa) in a cell-based model of hemostasis [J].

Hoffman, M ;

Monroe, DM .

DM DISEASE-A-MONTH, 2003, 49 (01) :14-21

[9] Recombinant factor VIIa enhances deposition of platelets with congenital or acquired αIIBβ3 deficiency to endothelial cell matrix and collagen under conditions of flow via tissue factor-independent thrombin generation [J].

Lisman, T ;

Moschatsis, S ;

Adelmeijer, J ;

Nieuwenhuis, HK ;

De Groot, PG .

BLOOD, 2003, 101 (05) :1864-1870

[10] Recombinant factor VIIa improves clot formation but not fibrolytic potential in patients with cirrhosis and during liver transplantation [J].

Lisman, T ;

Leebeek, FWG ;

Meijer, K ;

Van Der Meer, J ;

Nieuwenhuis, HK ;

De Groot, PG .

HEPATOLOGY, 2002, 35 (03) :616-621

← 1 2 →